DROTAVERINE 80mg. IP

An antispasmodic medication primarily used to treat various conditions characterized by smooth muscle spasms. A potent spasmolytic drug that acts directly on the smooth muscles and is devoid of any anticholinergic side effects. (Nijhawan, 2021) A safe and effective pharmaceutical agent for addressing recurrent abdominal pain. (Xing-cun Xue, 2017) Alleviates spasmodic pain originating from conditions involving smooth muscles, such as IBS, as well as cases of intestinal, biliary, or ureteric colic. (Nijhawan, 2021) Exerts a dual antispasmodic action on gut muscles: blocking calcium-calmodulin-induced contractions and inhibiting the phosphodiesterase (PDE) enzyme system. (Nijhawan, 2021) Provides substantial improvement in abdominal symptoms among individuals diagnosed with irritable bowel syndrome. (Ramesh R. Rai, 2014) Exerts a positive relaxing impact on smooth muscles within the intestines. Effectively alleviates abdominal pain by targeting the underlying muscle spasms. Significantly lessens the severity of all abdominal pain symptoms and alleviates the impact of these symptoms on day-to-day tasks. (Piotr Eder, 2022) Exhibits superior efficacy and better tolerability compared to alternative antispasmodics or ketoprofen in individuals experiencing abdominal pain or cramps. (Piotr Eder, 2022) Shows remarkable superiority in effectiveness over mebeverine in reducing the severity of pain, frequency, and symptoms related to stool in cases of IBS. (Nijhawan, 2021) Displays notably greater improvement in alleviating abdominal pain and bowel symptoms, as compared to those treated with mebeverine. (Nijhawan, 2021) Shows a significant improvement in the pain severity compared to mebeverine. (Nijhawan, 2021)